ASX:WESMultiline Retail
Assessing Wesfarmers (ASX:WES) Valuation After Infinity Pharmacy Group’s Priceline Administration News
Wesfarmers (ASX:WES) is back in focus after more than 50 Priceline pharmacies tied to Infinity Pharmacy Group went into administration, which has sharpened attention on execution risks in its expanding health and pharmacy division.
See our latest analysis for Wesfarmers.
The latest concerns around Infinity Pharmacy Group land at a time when Wesfarmers’ A$81.56 share price is already consolidating after a weaker 90 day share price return, even as its one year total shareholder return of 18.95...